Vita Therapeutics and I Peace Join Forces to Deliver Gene-Edited Stem Cells for Muscular Dystrophy
The companies will collaborate to leverage gene editing and GMP iPSC manufacturing to hopefully deliver new therapies.
Neurology
Hope Biosciences Launches Phase Ib/IIa Stem Cell Trial for Early Alzheimer’s Disease
Hope Biosciences will study whether stem cell therapy can reduce inflammation or slow Alzheimer’s progression in a new clinical trial.
FDA Grants Orphan Drug Designation to KLTO-202 Gene Therapy for ALS Treatment
Klotho Neurosciences’ gene therapy is advancing plans for ALS clinical trials next year.
Stem Cell and Spinal Stimulation Trial for Chronic Spinal Cord Injury
The study will test whether combining umbilical cord stem cells and spinal cord stimulation can safely help people with chronic spinal cord injury.
Intranasal Stem Cell Therapy: A Nasal Gateway to the Brain Shows Promise for CNS Diseases
For decades, treating diseases of the central nervous system (CNS) with stem cells has been hampered by one persistent biological obstacle: the blood–brain barrier (BBB). While the BBB protects the brain from...
FDA Reevaluating ALS Stem Cell Data following Citizen Petition – NurOwn from BrainStorm Cell Therapeutics
The FDAs new faces are feeling the pressure from patients and advocates on speeding up potential ALS therapies
NurExone reports enhanced scalability and clinical readiness for upcoming exosome-based clinical trials for neurological conditions
The Israeli regenerative medicine company is moving one step closer to clinical trials for serious neurological indications such as TBI, spinal cord injury, etc.
BrainStorm’s ALS stem cell treatment reports 90% survival over 5 years in expanded access program
BrainStorm's NurOwn, its ALS candidate stem cell therapy, has shown significantly higher five-year survival rates compared to expectations in a small 10 participant program.
UniXell Biotechnology doses first Parkinson’s patient with iPSCs, reports improvements
The Chinese biotech company reports that the patient showed notable improvements in sleep quality and motor function, with no serious adverse events.
Trailhead Biosystems launches iPSCs for blood-brain barrier and neurological research
Researchers may now have a new tool to unlock insights into blood-brain barrier regulation and neurological disease mechanisms.
